The role of porosity in the longevity of polymethylmethacrylate (PMMA) bone cement mantles remains unclear, although porosity reduction is probably desirable. It is not known whether pore patterns, pore distribution or pore morphology contribute to failure, since it is difficult to assess these features with traditional techniques. We used a novel microtomographic technique to quantitatively and qualitatively assess porosity in PMMA cements of differing viscosities to establish whether pore distribution can be effectively assessed and to document any differences in porosity (in both quantity, distribution and morphology). Each cement was also examined with and without the addition of vacuum, since this is thought to reduce porosity. Four PMMA bone cements of different viscosities (three of the same brand and the fourth chosen due to its popularity) were prepared and moulded according to established protocols (ASTM F451-99a), with and without the addition of vacuum. 25 samples per group (200 total) were prepared and densities for each sample calculated using Archimedes' principle. Four samples per group (total 32) were randomly selected for further analysis. These samples underwent micro-computer tomography (micro-CT) at a magnification of 20× and slice thickness of 13.67μm and reconstructed images were analysed with in-house developed software to measure pore size and volume. Results were analysed and compared with the two-sample T-test assuming significance at P<0.05. Qualitative assessment of pore character and distribution was made using three dimensional (3D) reconstruction.Introduction
Methods and materials
NSAID’s cycle-oxygenase (COX) inhibitory characteristics are either non-specific, COX-1 preferential or recently COX-2 preferential. NSAID’s have been widely reported to delay fracture repair however the mechanism of this affect remains unclear. Left femoral osteotomies were performed in 54 male 3 month old CFLP mice immobilised with uniplanar external fixators. 27 externally fixated mice received 4mg/kg meloxicam,b.d., from the day of surgery, by gavage. The control group received the carrier alone. 18 mice had external fixators applied to intact femurs and received no meloxicam as a sham control. Individual mouse movement, was quantified each day by autocounters using an infrared beam motion detection system. Plasma was obtained by right ventricular aspiration under anaesthesia on days 2,4,8 and 16-post surgery. A validated bioassay and a slot blotting immunoassay were employed to determine the plasma concentration of 11-6 and relative TNF-α levels to normal mouse serum. TNF-α levels peaked at day 4 and were suppressed by COX-2 inhibition. Both the control and treatment groups had higher levels of TNF-α than the non-fractured controls. The plasma concentration of 11-6 was elevated by COX-2 inhibition at all time points. The levels of TNF-α and 11-6 correlated in fracture control and treatment groups (Spearman’s 0.039 and 0.002 respectively). The 11-6 plasma concentration correlated to the animal motion in the treatment group alone (Spearman’s 0.017). As it has been shown that TNF-α induces 11-6 production and that this inhibits TNF-α production a possible model for these interaction is shown below.